Login / Signup
Potential cancer risk with omalizumab? A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.
Diogo Mota
Tiago Azenha Rama
Milton Severo
Vanessa Garcia-Larsen
Published in:
Allergy (2021)
Keyphrases
</>
adverse drug
human health
emergency department
risk assessment
climate change